


Catalog · Wellness
PT-141
CAS 189691-06-3MW 1,025.2 g/mol≥99.0% Purity
A melanocortin receptor agonist studied for MC3R/MC4R signaling in research models.
Quantity per vial
Vials
1
$44.99
- Free cold-chain shipping over $200
- Signed COA included with every vial
- Batch-pinned ordering for protocol continuity
Research Use Only. Sold for research and identification purposes only. Not intended for human dosing, injection, or ingestion.
Mass-Spec Verified
HPLC + LC-MS per batch at Janoshik.
99% Purity Threshold
Below-spec lots are destroyed, not sold.
Cold-Chain 2–8°C
Continuous transit temperature logging.
U.S. cGMP Compounded
Domestic manufacturing, lot traceability.
Mechanism of action
PT-141 (bremelanotide) is a cyclic heptapeptide analog of α-MSH that acts as an agonist at the melanocortin receptors, principally MC3R and MC4R. Research models study its central-nervous-system melanocortin-pathway signaling.
Unlike peripheral vasoactive compounds, it is investigated for receptor-mediated central signaling, which is the focus of its research literature.